drugset / Trial / NCT03122301

Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer

NCT03122301 ↗

RandomizedParallel-groupSingle-blindSupportive care

Summary

Vasomotor symptoms (hot flashes, night sweats, VMS) affect up to 65% of breast cancer survivors and negatively impact their quality of life. VMS in Hispanic women are significantly more severe as compared to non-Hispanic Caucasian women. Few effective treatments for VMS are available, especially in the underserved Hispanic and Spanish-speaking populations which is problematic, as Hispanics will comprise 20% of the U.S. population by 2025. Stellate ganglion nerve block (SGB) with local anesthetic, previously performed for chronic pain indications, has shown promise as a potential treatment for menopausal women with VMS in previous clinical trials, but has not been investigated in Hispanic or Spanish-Speaking women with breast cancer in a controlled study.

Timeline

Start
2017-06-01
Primary completion
2020-07-01
Completion
2020-07-01

Outcome

Outcome not reported

Stopped (Enrollment): “Study stopped due to inadequate enrollment.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivicaine Other / unclassified — —

Indications

No indication recorded.